Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
31.58 USD42.56 USD53.65 USD
+22.34%
42.56 USDCurrent price is 22.4% above the base model value.
T
US
TECH.US · BIO-TECHNE Corp
US · US
Latest price52.07 USD
30D+3.25%
Vs. base value+302%
Research summary
TECH.US latest organized financial period shows revenue grew +5.23% YoY and net income declined -56.34% YoY. Current price is about 52.07 USD, while the model base case is about 12.94 USD; the current price sits +302% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue1B USD
Net income73M USD
Free cash flow257M USD
Operating cash flow288M USD
Price trend
Price date: 2026/04/29 · Updated: 2026/04/29 15:24
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price52.07 USD
Base value12.94 USD
Vs. base+302%
Price date2026/04/29
13.84 USD12.94 USD16.22 USD
+302%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
13.84 USD12.94 USD16.22 USD
+302%
12.94 USDCurrent price is 302.4% above the base model value.Adjusted reference: 18.31 USD
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth11.3%
Current price implies roughly 11.3% annualized FCF growth.
11.3%Current price implies roughly 11.3% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
11.15 USD11.15 USD11.15 USD
+367%
11.15 USDCurrent price is 367.1% above the base model value.
Updated: 2026/04/29 15:24
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
ExpandCollapse
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2024/06/30 | Restructuring charges | Restructuring | -10M USD | Medium |
| 2023/06/30 | Restructuring charges | Restructuring | -6M USD | Medium |
| 2022/06/30 | Restructuring charges | Restructuring | -4M USD | Medium |
| 2021/06/30 | Restructuring charges | Restructuring | -224K USD | Medium |
| 2020/06/30 | Restructuring charges | Restructuring | -69K USD | Medium |
| 2024/06/30 | Restructuring charges | Restructuring | -17M USD | Medium |
| 2024/03/31 | Restructuring charges | Restructuring | -2M USD | Medium |
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 14
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/06/30 | Annual | 1B USD | 73M USD | - | 257M USD | 0.46 | - |
| 2024/06/30 | Annual | 1B USD | 168M USD | 178M USD | 236M USD | 1.05 | 1.11 |
| 2023/06/30 | Annual | 1B USD | 285M USD | 291M USD | 216M USD | 1.76 | 1.8 |
| 2022/06/30 | Annual | - | 272M USD | 276M USD | 280M USD | 6.63 | 6.73 |
| 2021/06/30 | Annual | - | 140M USD | 141M USD | 308M USD | 3.47 | 3.48 |
Ad placement